View Item 
  •   e_Buah Home
  • INVESTIGACIÓN
  • DEPARTAMENTOS
  • Ciencias Biomédicas
  • Unidad docente Farmacología
  • FARMACOL - Artículos
  • View Item
  • INVESTIGACIÓN
  • DEPARTAMENTOS
  • Ciencias Biomédicas
  • Unidad docente Farmacología
  • FARMACOL - Artículos
  • View Item
  • Biblioteca
    • English
    • español
JavaScript is disabled for your browser. Some features of this site may not work without it.

Mutational Pathways, Resistance Profile, and Side Effects of Cyanovirin Relative to Human Immunodeficiency Virus Type 1 Strains with N-Glycan Deletions in Their gp120 Envelopes

Show full item record
RefworksUtilizar EndNote Import
Authors
Balzarini, Jan; Van Laethem, Kristel; Peumans, Willy J.; Van Damme, Els J. M.; Bolmstedt, Anders; [et al.]
Identifiers
Permanent link (URI): http://hdl.handle.net/10017/5045
DOI: 10.1128/JVI.00369-06
Publisher
American Society for Microbiology
Date
2006
Affiliation
Universidad de Alcalá. Departamento de Farmacología
Bibliographic citation
JOURNAL OF VIROLOGY, Sept. 2006, p. 8411-8421
Document type
info:eu-repo/semantics/article
Version
info:eu-repo/semantics/publishedVersion
Publisher's version
http://dx.doi.org/10.1128/JVI.00369-06
Access rights
info:eu-repo/semantics/openAccess
Share
 
Abstract
Limited data are available on the genotypic and phenotypic resistance profile of the alpha-(1-2)mannose oligomer-specific prokaryotic lectin cyanovirin (CV-N). Therefore, a more systematic investigation was carried out to obtain a better view of the interaction between CV-N and human immunodeficiency virus type 1 (HIV-1) gp120. When HIV-1-infected CEM cell cultures were exposed to CV-N in a dose-escalating manner, a total of eight different amino acid mutations exclusively located at N-glycosylation sites in the envelope surface gp120 were observed. Six of the eight mutations resulted in the deletion of high-mannose type N-glycans (i.e., at amino acid positions 230, 332, 339, 386, 392, and 448). Two mutations (i.e., at position 136 and 160) deleted a complex type N-glycan in the variable V1/V2 domain of gp120. The level of phenotypic resistance of the mutated virus strains against CV-N generally correlated with the number of glycan deletions in gp120, although deletion of the glycans at N-230, N-392, and N-448 generally afforded a more pronounced CV-N resistance than other N-glycan deletions. However, the extent of the decrease of antiviral activity of CV-N against the mutated virus strains was markedly less pronounced than observed for alpha(1-3)- and alpha(1-6)-mannose-specific plant lectins Hippeastrum hybrid agglutinin (HHA) and Galanthus nivalis agglutinin (GNA), which points to the existence of a higher genetic barrier for CV-N. This is in agreement with a more consistent suppression of a wider variety of HIV-1 clades by CV-N than by HHA and GNA. Whereas the antiviral and in vitro antiproliferative activity of CV-N can be efficiently reversed by mannan, the pronounced mitogenic activity of CV-N on peripheral blood mononuclear cells was unaffected by mannan, indicating that some of the observed side effects of CV-N are unrelated to its carbohydrate specificity/activity.
Files in this item
FilesSizeFormat
View
841.pdf437.7KbPDF
FilesSizeFormat
View
841.pdf437.7KbPDF
Collections
  • FARMACOL - Artículos [13]

Contact Us | Send Feedback | About DSpace
¡CSS Válido!@mire NV
¡CSS Válido!@mire NV
 

 

Browse

All of e_BuahCommunities y CollectionsIssue DateAuthorsTitlesSubjectsIn this CollectionIssue DateAuthorsTitlesSubjects

My Account

My e_BuahCreate account

Help

What is e-Buah?Guide e_BuahGuide autoarchiveFAQContact us

Statistics

View Usage Statistics

Information

Open Science. Open accessOpen access PolicyPublishing permissionsCopyrightResearch datae-cienciaDatos RepositoryPlan de Gestión de Datos

Los contenidos se difunden en


Contact Us | Send Feedback | About DSpace
¡CSS Válido!@mire NV
¡CSS Válido!@mire NV